Achalasia

Minerva Gastroenterologica e Dietologica

Volumn 54, Issue 3, 2008, Pages 277-285

  Dughera, L ^a   Cassolino, P ^a   Cisaro F ^a   Chiaverina, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Botulinum toxins; Esophageal achalasia; Laparoscopy; Manometry

Indexed keywords

BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; NITRATE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL;

CARDIOESOPHAGOMYOTOMY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG EFFECT; EARLY DIAGNOSIS; ENDOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS MOTILITY; HEADACHE; HUMAN; HYPOTENSION; MANOMETRY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; RADIODIAGNOSIS; REVIEW; THORAX PAIN;

ANTI-DYSKINESIA AGENTS; BALLOON DILATATION; BOTULINUM TOXINS; CALCIUM CHANNEL BLOCKERS; DRUG THERAPY, COMBINATION; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGECTOMY; ESOPHAGOSCOPY; EVIDENCE-BASED MEDICINE; HUMANS; INJECTIONS, INTRALESIONAL; MANOMETRY; NITRATES; PHOSPHODIESTERASE INHIBITORS; TREATMENT OUTCOME;

EID: 57449117531     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Willis T. Pharmaceutice rationalis sive diatriba do medicamentorum operationibus in humano corpore. London: Hagea Comitis, 1674.
2. Birgisson S, Richter JE. Achalasia: what's new in diagnosis and treatment? Dig Dis 1997;15(Suppl 1):1-27.
3. Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005;100:1404-14.
4. Prakash C, Clouse RE. Esophageal motor disorders. Curr Opin Gastroenterol 1999;15:339.
5. Wong RK, Maydonovitch CC. Achalasia. In: Castell DO, editor. The oesophagus. Boston: Little, Brown and Co.; 1995. p. 219-45.
6. Vaezi MF. Achalasia: diagnosis and management. Semin Gastrointest Dis 1999;10:103-12.
7. Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999;44:231-9.
8. Mikaeli J, Farrokhi F, Bishehsari F, Mandavinia M, Malekzadeh R. Gender effect on clinical features of achalasia: a prospective study. BMC Gastroenterol 2006;6:12.
9. Vela ME, Vaezi MF. Cost-assessment of alternative management strategies for achalasia. Expert Opin Pharmacother 2003;4:2019-25.
10. Zárate N, Mearin F, Gil-Vernet JM, Camarasa F, Malagelada JR. Achalasia and Down's syndrome: coincidental association or something else? Am J Gastroenterol 1999;94:1674-7.
11. Zaninotto G, Annese V, Costantini M, Del Genio A, Costantino M, Epifani M et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg 2004;239:364-70.
12. Wong RK, Maydonovitch CL, Metz SJ, Baker JR Jr. Significant DQw1 association in achalasia. Dig Dis Sci 1989;34:349-52.
13. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, Fernandez AM, Perez-de-la-Serna J, Gonzalez VA et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002;47:15-9.
14. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993;34:299-302.
15. Birgisson S, Galinski MS, Goldblum JR, Rice TW, Richter JE. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci 1997;42:300-6.
16. Verne GN, Sallustio JE, Eaker EY. Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci 1997;42:307-13.
17. Annese V, Napolitano G, Minervini MM, Perri F, Ciavarella G, Di Giorgio G et al. Family occurrence of achalasia. J Clin Gastroenterol 1995;20:329-30.
18. Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000;26:332-5.
19. de Borst JM, Wagtmans MJ, Focken P, van Lanschot JJ, West R, Boeckxstaens GE. Pseudoachalasia caused by pancreatic carcinoma. Eur J Gastroenterol Hepatol 2003;15:825-8.
20. Parkman HP, Cohen S. Malignancy-induced secondary achalasia. Dysphagia 1994;9:292-6.
21. Portale G, Costantini M, Zaninotto G, Ruol A, Guirroli E, Rampado S et al. Pseudoachalasia: not only esophago-gastric cancer. Dis Esophagus 2007;20:168-72.
22. Bonavina L, Bona D, Saino G, Clemente C. Pseudoachalasia occurring after laparoscopic Nissen fundoplication and crural mesh repair. Langenbecks Arch Surg 2007;392:653-6.
23. Chuah SK, Kuo CM, Wu KL, Changchien CS, Hu TH, Wang CC et al. Pseudoachalasia in a patient after truncal vagotomy surgery successfully treated by subsequent pneumatic dilations. World J Gastroenterol 2006;12:5087-90.
24. Aggestrup S, Uddman R, Sundler F, Fahrenkrug J, Håkanson R, Sørensen HR et al. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology 1983;84:924-7.
25. Lundgren O. Vagal control of the motor functions of the lower esophageal sphincter and the sumach. J Auton New Syst 1983;9:185-97.
26. Uddman R, Luts A, Absood A, Arimura A, Ekelund M, Desai H et al. PACAP, a VIP-like peptide, in neurons of the esophagus. Regul Pept 1991;36:415-22.
27. Hirsch DP, Holloway RH, Tytgat GN, Boeckxstaens GE. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology 1998;115:1374-80.
28. Konturek JW, Thor P, Lukaszyk A, Gabryelewicz A, Konturek S J, Domschke W. Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol 1997;48:201-9.
29. Yamato S, Spechler SJ, Goyal RK. Role of nitric oxide in esophageal peristalsis in the opossum. Gastroenterology 1992;103:197-204.
30. Zayat EN, Schuster MM. Nitric oxide - a major player in esophageal motility. Am J Gastroenterol 2000;95:1584-5.
31. Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993;23:724-8.
32. Cassella RR, Brown Al jr., Sayre GP, Ellis FH jr. Achalasia of the esophagus: pathologic and etiologic considerations. Ann Surg 1964;160:474-87.
33. Higgs B, Kerr FW, Ellis FH Jr. The experimental production of esophageal achalasia by electrolytic lesions in the medulla. J Thorac Cardiovasc Surg 1965;50:613-25.
34. Atkinson M, Ogilvie AL, Robertson CS, Smart HL. Vagal function in achalasia of the cardia. Q J Med 1987;63:297-303.
35. Eckardt VF, Krause J, Bolle D. Gastrointestinal transit and gastric acid secretion in patients with achalasia. Dig Dis Sci 1989;34:665-71.
36. Khajanchee YS, VanAndel R, Jobe BA, Barra MJ, Hansen PD, Swantrom LL. Electrical stimulation of the vagus nerve restores motility in an animal model of achalasia. J Gastrointest Surg 2003;7:843-9.
37. Faussone-Pellegrini MS, Cortesini C. Ultrastructural features and localization of the interstitial cells of Cajal in the smooth muscle coat of human esophagus. J Suhmicrosc Cytol 1985;17:187-97.
38. Szurszewski JH, Farrugia G. Carbon monoxide is an endogenous hyperpolarizing factor in the gastrointestinal tract. Neurogastroenterol Motil 2004;16:81-5.
39. Fox EA, Phillips RJ, Martinson FA, Baronowsky EA, Powley TL. C-Kit mutant mice have a selective loss of vagal intramuscular niechanoreceptors in the forestomach. Anat Embryol (Berl) 2001;204:11-26.
40. Sanders K M. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996; 111:492-575.
41. Ward SM, Morris G, Reese L, Wang XV, Sanders KM. Interstitial cells of Cajal mediate enteric inhibitory neurotransmission in the lower esophageal and pyloric sphincters. Gastroenterology 1998;115:314-29.
42. Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 1995;373:347-9.
43. Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986;90:924-9.
44. Greaves RR, Mulcahy HE, Patchett SE, Gorard DA, Fairclough PD, Alstead EM et al. Early experience with intrasphincteric botulinum toxin in the treatment of achalasia. Aliment Pharmacol Ther 1999;13:1221-5.
45. Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 1981;80:327-33.
46. Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Aehalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 1994;18:327-37.
47. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996;111:648-54.
48. Katz PO, Richter JE, Cowan R, Castell DO. Apparent complete lower esophageal sphincter relaxation in achalasia. Gastroenterology 1986;90:978-83.
49. Ott DJ, Richer JE, Chen YM, Wu WC, Gelfand DW, Castell DO. Radiographic and manometric correlation in achalasia with apparent relaxation of the lower esophageal sphincter. Gastrointest Radiol 1989;14:1-5.
50. Amaravadi R, Levine MS, Rubesin SE, Redfern RO, Katzka DA. Achalasia with complete relaxation of the lower esophageal sphincter: radiographicmanometric correlation. Radiology 2005;235:886-91.
51. Woodfield CA, Levine MS, Rubesin SE, Langlotz CP, Laufer I. Diagnosis of primary versus secondary achalasia: reassessment of clinical and radiographic criteria. AJR 2000;175:727-31.
52. Clouse RE, Staiano A. Manometric patterns using esophageal body and lower sphincter characteristics. Findings in 103 patients. Dig Dis Sci 1992;37:289-96.
53. Spechler SJ. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999;117:233-54.
54. Dudnick RS, Castell JA, Castell DO. Abnormal upper esophageal sphincter function in achalasia.Am J Gastroenterol 1992;87:1712-5.
55. Saha HK, Sengupta JN, Goyal RK. Role of chloride ions in lower esophageal sphincter tone and relaxation.Am J Physiol 1992;263:G115-26.
56. Zhang ZG, Diamant NE. Repetitive contractions of the upper esophageal body and sphincter in achalasia. Dysphagia 1994;9:12-9.
57. Massey BT, Hogan WJ, Dodds WJ, Dantas HO. Alteration of the upper esophageal sphincter belch reflex in patients with achalasia. Gastroenterology 1992;103:1574-9.
58. Bortolotti M, Labo G. Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 1981;80:39-44.
59. Triadafilopoulos G, Aaronson M, Sackel S, Burakoff R. Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil, and placebo. Dig Dis Sci 1991;36:260-7.
60. Traube M, Dubovik S, Lange RC, McCallum RW. The role of nifedipine therapy in achalasia: results of a randomized, doubleblind, placebo-controlled study. Am J Gastroenterol 1989;84:1259-62.
61. Wen ZH, Gardener E, Wang YP. Nitrates for achalasia. Cochrane Database Syst Rev 2004:CD002299.
62. Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 2000;118:253-7.
63. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;332:774-8.
64. Annese V, Basciani M, Perri F, Lombardi G, Frusciante V, Simone P et al. Controlled trial of botulinum toxin injection vs. placebo and pneumatic dilatation in achalasia. Gastroenterology 1996;111:1418-24.
65. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994;121:590-1.
66. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphineteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;332:774-8.
67. Annese V, Bassotti G. Non-surgical treatment of esophageal achalasia. World J Gastroenterol 2006;12:5763-6.
68. Fishman VM, Parkman HP, Schiano TD, Hills C, Dabezies MA, Cohen S et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996;91:1724-30.
69. Annese V, Bassotti G, Coccia G, Dinelli M, D'Onofrio V, Gatto G et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 2000;46:597-600.
70. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996;110:1410-5.
71. Pehlivanov N, Pasricha PJ: Achalasia: botox, dilatation or laparoscopic surgery in 2006. Neurogastroenterol Motil 2006;18:799-804.
72. Eckardt VF, Aignherr C, Bernhard G. Predictors of outconic in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992;103:1732-8.
73. Achkar E. Achalasia, Gastroenterologist 1995;3:273-88.
74. Richter JE: Modern management of achalasia. Curr Treat Options Gastroenterol 2005;8:275-83.
75. Dughera L, Battaglia E, Maggio D, Cassolino P, Mioli PR, Morelli A et al. Botulinum toxin treatment of oesophageal achalasia in the old old and oldest old: a 1-year follow-up study. Drugs Aging 2005;22:779-83.
76. Mikaeli J, Bishehsari F, Montazeri G, Yaghoobi M, Malekzadeh R. Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters. Aliment Pharmacol Ther 2004;20:431-6.
77. Kadakia SC, Wong RK. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol 1993;88:34-8.
78. Wong RK. Pneumatic dilation for achalasia. Am J Gastroenterol 2004;99:578-80.
79. Zerbib F, Thetiot V, Richy F, Benajah DA, Message L, Lamouliatte H. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006;101:692-7.
80. Ishaq S. Treatment of achalasia: the role of laparoscopic cardiomyotomy needs to be emphasized. Am J Gastroenterol 2004;99:2278-9; author reply 2279.
81. Csendes A, Braghetto I, Mascaro J, Henriquez A. Late subjective and objective evaluation of the results of esophagomyotomy in 100 patients with achalasia of the esophagus. Surgery 1988;104:469-75.
82. Mineo TC, Ambrogi V. Long-term results and quality of life after surgery for oesophageal achalasia: one surgeon's experience. Eur J Cardiothorac Surg 2004;25:1089-96.
83. Patti MG, Fisichella PM, Perretta S, Galvani C, Gorodner MV, Robinson T et al. Impact of minimally invasive surgery on the treatment of esophageal achalasia: a decade of change. J Am Coll Surg 2003;196:698-703; discussion 703-5.
84. Virginia R. Litle. Laparoscopic Heller myotomy for achalasia: a review of the controversies. Ann Thorac Surg 2008;85:S743-6.